Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Urology · Zhongshan Hospital · Shanghai

Dr. Chen Wei陈伟

Associate Chief Physician
Department head

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Chen Wei

Professional overview

Dr. Chen Wei is an Associate Chief Physician in the Department of Urology at Zhongshan Hospital, specializing in minimally invasive and comprehensive treatment of urologic malignancies, including prostate cancer, renal cancer, adrenal tumors, and upper urinary tract and bladder tumors.

SpecialtyUrology
Clinical titleAssociate Chief Physician
Academic rolesMaster's Supervisor
DepartmentDepartment of Urology
HospitalZhongshan Hospital
CityShanghai
Hospital roleDirector of the Prostate Tumor Subspecialty

Department leadership

Department head

A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.

Areas of focus

Minimally invasive surgeryIncludes robotic surgery, laparoscopy, single-port laparoscopy, ultra-minimally invasive needle-based laparoscopy, and urethral sling for urinary incontinence
Prostate cancerMicrosurgical radical prostatectomy, multidisciplinary team management, and technical modifications for laparoscopic prostatectomy
Renal cancerLaparoscopic partial nephrectomy with remote-controlled arterial clamping, and needle-based laparoscopic nephrectomy

Background

  • 2007Graduated from Shanghai Medical College, Fudan University
  • 2012Selected as the first cohort of the Shanghai Municipal Health and Family Planning Commission’s Young Physician Training Program
  • 2012Began a one-year training program in advanced uro-oncology at The University of Texas MD Anderson Cancer Center and Johns Hopkins Hospital, USA (February 2012–May 2013)
  • 2013First-inventor patent 'Safety-Type Cystoscopic Resection Loop for Bladder Tumors' awarded Bronze Prize at the Shanghai Invention Selection Contest
  • 2014Served on the National Medical Team for mobile medical services in Xinjiang; performed the first laparoscopic nephrectomy at the local hospital
  • 2015First-inventor patent 'Remote-Controlled Arterial Clamp for Laparoscopic Nephron-Sparing Surgery' successfully transferred to Nantong Yikai Medical Instrument Co., Ltd.; results published in Journal of Endourology
  • 2016Performed over 100 ultra-minimally invasive transumbilical single-port and needle-based laparoscopic procedures, including pyelolithotomy, adrenalectomy, and partial nephrectomy
  • 2017Awarded First Prize in the Video Competition of the Chinese Anti-Cancer Association Urological Oncology Youth Committee
  • 2017Delivered an invited presentation titled 'Remote Arterial Occlusion in Laparoscopic Partial Nephrectomy' at the American Urological Association (AUA) Annual Meeting in Boston
  • 2018Delivered an invited presentation titled 'Techniques and Modifications of Laparoscopic Radical Prostatectomy' at the AUA Annual Meeting in San Francisco
  • 2019Delivered an invited presentation titled 'Application and Modification of Needle-Based Laparoscopy in Urology' at the AUA Annual Meeting in Boston; awarded the 'Rising Star Award' by the World Chinese Urological Association
  • 2020New technology 'Modified Needle-Based Ultra-Minimally Invasive Laparoscopy in Urology' certified as a new clinical technique by Zhongshan Hospital, Fudan University
  • 2020Awarded Second Prize of the Shanghai Medical Science and Technology Award
  • 2023Awarded Outstanding Young Graduate Supervisor by Zhongshan Hospital, Fudan University
  • 2024Appointed Vice Chair of the Precision Therapy Committee for Urologic Tumors, China Primary Health Care Foundation

Experience & recognition

  • Over 30 peer-reviewed publications as first or corresponding author, including 20 SCI-indexed papers
  • Two granted national invention patents (first inventor), two utility model patents (first inventor), and two successful patent transfers
  • Three surgically modified techniques developed and clinically implemented
  • Contributed to two authoritative monographs, including Practical Surgery
  • Awarded 'Yi Yuan Xin Xing' (Medical Garden New Star) by Shanghai

Professional roles

  • Member, Urological Oncology Committee, China Anti-Cancer Association (CACA)
  • Vice Chair, Precision Therapy Committee for Urologic Tumors, China Primary Health Care Foundation
  • Member, Prostate Health and Counseling Expert Committee, Asian Society of Andrology
  • Member, Youth Committee, Shanghai Association of Integrative Medicine – Urology and Andrology Branch
  • Member, Shanghai Association of Integrative Medicine (Standing position confirmed: 'Council Member')
  • Member, Asian Urological Surgical Training and Education Group
  • Supervisory Expert, Shanghai Clinical Quality Control Center
  • Research Scholar, Shanghai Medical College, Fudan University

Frequently asked questions

What does Dr. Chen Wei specialize in?

Specializes in minimally invasive and comprehensive treatment of urologic malignancies—including prostate cancer, renal cancer, adrenal tumors, and upper urinary tract and bladder tumors—as well as ultra-minimally invasive needle-based laparoscopy, single-port laparoscopy, robotic surgery, and urethral sling for urinary incontinence.

Which hospital and department is Dr. Chen Wei in?

Department of Urology at Zhongshan Hospital

Sources

Dr. Chen Wei has not reviewed this page.